关注
Vladimir Razinkov
Vladimir Razinkov
在 amgen.com 的电子邮件经过验证
标题
引用次数
引用次数
年份
High throughput thermostability screening of monoclonal antibody formulations
F He, S Hogan, RF Latypov, LO Narhi, VI Razinkov
Journal of pharmaceutical sciences 99 (4), 1707-1720, 2010
2132010
Effective charge measurements reveal selective and preferential accumulation of anions, but not cations, at the protein surface in dilute salt solutions
YR Gokarn, RM Fesinmeyer, A Saluja, V Razinkov, SF Chase, TM Laue, ...
Protein Science 20 (3), 580-587, 2011
1542011
Acid-induced aggregation of human monoclonal IgG1 and IgG2: molecular mechanism and the effect of solution composition
SB Hari, H Lau, VI Razinkov, S Chen, RF Latypov
Biochemistry 49 (43), 9328-9338, 2010
1472010
High-throughput dynamic light scattering method for measuring viscosity of concentrated protein solutions
F He, GW Becker, JR Litowski, LO Narhi, DN Brems, VI Razinkov
Analytical biochemistry 399 (1), 141-143, 2010
1432010
Biophysical characterization of influenza virus subpopulations using field flow fractionation and multiangle light scattering: correlation of particle counts, size distribution …
Z Wei, M Mcevoy, V Razinkov, A Polozova, E Li, J Casas-Finet, GI Tous, ...
Journal of virological methods 144 (1-2), 122-132, 2007
1152007
High‐throughput assessment of thermal and colloidal stability parameters for monoclonal antibody formulations
F He, CE Woods, GW Becker, LO Narhi, VI Razinkov
Journal of pharmaceutical sciences 100 (12), 5126-5141, 2011
1112011
Effect of sugar molecules on the viscosity of high concentration monoclonal antibody solutions
F He, CE Woods, JR Litowski, LA Roschen, HS Gadgil, VI Razinkov, ...
Pharmaceutical research 28, 1552-1560, 2011
1072011
Native-state solubility and transfer free energy as predictive tools for selecting excipients to include in protein formulation development studies
DD Banks, RF Latypov, RR Ketchem, J Woodard, JL Scavezze, CC Siska, ...
Journal of pharmaceutical sciences 101 (8), 2720-2732, 2012
1062012
RFI-641 inhibits entry of respiratory syncytial virus via interactions with fusion protein
V Razinkov, A Gazumyan, A Nikitenko, G Ellestad, G Krishnamurthy
Chemistry & biology 8 (7), 645-659, 2001
1002001
A novel antibody engineering strategy for making monovalent bispecific heterodimeric IgG antibodies by electrostatic steering mechanism
Z Liu, EC Leng, K Gunasekaran, M Pentony, M Shen, M Howard, J Stoops, ...
Journal of Biological Chemistry 290 (12), 7535-7562, 2015
942015
Aggregation of anti-streptavidin immunoglobulin gamma‐1 involves Fab unfolding and competing growth pathways mediated by pH and salt concentration
N Kim, RL Remmele Jr, D Liu, VI Razinkov, EJ Fernandez, CJ Roberts
Biophysical chemistry 172, 26-36, 2013
932013
Screening of monoclonal antibody formulations based on high-throughput thermostability and viscosity measurements: design of experiment and statistical analysis
F He, CE Woods, E Trilisky, KM Bower, JR Litowski, BA Kerwin, ...
Journal of pharmaceutical sciences 100 (4), 1330-1340, 2011
892011
Accelerated formulation development of monoclonal antibodies (mAbs) and mAb-based modalities: review of methods and tools
VI Razinkov, MJ Treuheit, GW Becker
Journal of biomolecular screening 20 (4), 468-483, 2015
802015
Specific-ion effects on the aggregation mechanisms and protein–protein interactions for anti-streptavidin immunoglobulin gamma-1
GV Barnett, VI Razinkov, BA Kerwin, TM Laue, AH Woodka, PD Butler, ...
The Journal of Physical Chemistry B 119 (18), 5793-5804, 2015
792015
Effects of Spontaneous Bilayer Curvature on Influenza Virus–mediated Fusion Pores
VI Razinkov, GB Melikyan, RM Epand, RF Epand, FS Cohen
The Journal of general physiology 112 (4), 409-422, 1998
741998
How Well Do Low-and High-Concentration Protein Interactions Predict Solution Viscosities of Monoclonal Antibodies?
MA Woldeyes, W Qi, VI Razinkov, EM Furst, CJ Roberts
Journal of pharmaceutical sciences, 2018
712018
Detection of IgG aggregation by a high throughput method based on extrinsic fluorescence
F He, DH Phan, S Hogan, R Bailey, GW Becker, LO Narhi, VI Razinkov
Journal of pharmaceutical sciences 99 (6), 2598-2608, 2010
702010
Asymmetrical Fc engineering greatly enhances antibody-dependent cellular cytotoxicity (ADCC) effector function and stability of the modified antibodies
Z Liu, K Gunasekaran, W Wang, V Razinkov, L Sekirov, E Leng, H Sweet, ...
Journal of Biological Chemistry 289 (6), 3571-3590, 2014
652014
Sterols and sphingolipids strongly affect the growth of fusion pores induced by the hemagglutinin of influenza virus
VI Razinkov, FS Cohen
Biochemistry 39 (44), 13462-13468, 2000
532000
Precision of protein aggregation measurements by sedimentation velocity analytical ultracentrifugation in biopharmaceutical applications
JP Gabrielson, KK Arthur, MR Stoner, BC Winn, BS Kendrick, V Razinkov, ...
Analytical biochemistry 396 (2), 231-241, 2010
522010
系统目前无法执行此操作,请稍后再试。
文章 1–20